# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-110646
Filing Date
2023-10-23
Accepted
2023-10-23 07:10:42
Documents
16
Period of Report
2023-10-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2328928d1_8k.htm iXBRL | 8-K | 39636
2 | EXHIBIT 99.1 | tm2328928d1_ex99-1.htm | EX-99.1 | 19108
3 | EXHIBIT 99.2 | tm2328928d1_ex99-2.htm | EX-99.2 | 11823
7 | GRAPHIC | tm2328928d1_ex99-2img001.jpg | GRAPHIC | 889038
8 | GRAPHIC | image_001.jpg | GRAPHIC | 13602
| Complete submission text file | 0001104659-23-110646.txt |  | 1504203

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | syn-20231023.xsd | EX-101.SCH | 3042
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syn-20231023_lab.xml | EX-101.LAB | 34240
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syn-20231023_pre.xml | EX-101.PRE | 22378
10 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2328928d1_8k_htm.xml | XML | 3324

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 231338502
SIC: 2834 Pharmaceutical Preparations